Metastatic colorectal carcinoma patients: The Glasgow Prognostic Score (GPS) at the era of anti-EGFR therapies

被引：0
|
作者：
Dreanic, J. [1 ]
Maillet, M. [1 ]
Dhooge, M. [1 ]
Cessot, A. [2 ]
Mir, O. [2 ]
Brezault, C. [1 ]
Goldwasser, F. [2 ]
Chaussade, S. [1 ]
Coriat, R. [1 ]
机构：
[1] Paris Descartes Univ, Cochin Teaching Hosp, AP HP, Dept Gastroenterol, Paris, France
[2] Paris Descartes Univ, Cochin Teaching Hosp, AP HP, Dept Oncol, Paris, France
来源：
EUROPEAN JOURNAL OF CANCER | 2013年 / 49卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
2290
引用
收藏
页码：S525 / S525
页数：1
相关论文
共 50 条
  • [1] Prognostic value of the Glasgow Prognostic Score in metastatic colorectal cancer in the era of anti-EGFR therapies
    Dreanic, Johann
    Maillet, Marianne
    Dhooge, Marion
    Mir, Olivier
    Brezault, Catherine
    Goldwasser, Francois
    Chaussade, Stanislas
    Coriat, Romain
    MEDICAL ONCOLOGY, 2013, 30 (03)
  • [2] Prognostic value of the Glasgow Prognostic Score in metastatic colorectal cancer in the era of anti-EGFR therapies
    Johann Dréanic
    Marianne Maillet
    Marion Dhooge
    Olivier Mir
    Catherine Brezault
    François Goldwasser
    Stanislas Chaussade
    Romain Coriat
    Medical Oncology, 2013, 30
  • [3] Metastatic colorectal carcinoma patients: The Glasgow prognostic score (GPS) at the era of anti-VEGF therapies
    Maillet, M.
    Dreanic, J.
    Dhooge, M.
    Cessot, A.
    Mir, O.
    Brezault, C.
    Goldwasser, F.
    Chaussade, S.
    Coriat, R.
    EUROPEAN JOURNAL OF CANCER, 2013, 49 : S526 - S526
  • [4] Integrating anti-EGFR therapies in metastatic colorectal cancer
    Haraldsdottir, Sigurdis
    Bekaii-Saab, Tanios
    JOURNAL OF GASTROINTESTINAL ONCOLOGY, 2013, 4 (03) : 285 - 298
  • [5] Tumor budding predicts response to anti-EGFR therapies in metastatic colorectal cancer patients
    Zlobec, Inti
    Molinari, Francesca
    Martin, Vittoria
    Mazzucchelli, Luca
    Saletti, Piercarlo
    Trezzi, Rosangela
    De Dosso, Sara
    Vlajnic, Tatjana
    Frattini, Milo
    Lugli, Alessandro
    WORLD JOURNAL OF GASTROENTEROLOGY, 2010, 16 (38) : 4823 - 4831
  • [6] Tumor budding predicts response to anti-EGFR therapies in metastatic colorectal cancer patients
    Inti Zlobec
    Francesca Molinari
    Vittoria Martin
    Luca Mazzucchelli
    Piercarlo Saletti
    Rosangela Trezzi
    Sara De Dosso
    Tatjana Vlajnic
    Milo Frattini
    Alessandro Lugli
    World Journal of Gastroenterology, 2010, 16 (38) : 4823 - 4831
  • [7] Consensus recommendations for the use of anti-EGFR therapies in metastatic colorectal cancer
    Cripps, C.
    Gill, S.
    Ahmed, S.
    Colwell, B.
    Dowden, S.
    Kennecke, H.
    Maroun, J.
    Samson, B.
    Thirlwell, M.
    Wong, R.
    CURRENT ONCOLOGY, 2010, 17 (06) : 272 - 278
  • [8] The predictive and prognostic value of the Glasgow Prognostic Score in metastatic colorectal carcinoma patients receiving bevacizumab
    Maillet, Marianne
    Dreanic, Johann
    Dhooge, Marion
    Mir, Olivier
    Brezault, Catherine
    Goldwasser, Francois
    Chaussade, Stanislas
    Coriat, Romain
    ANTI-CANCER DRUGS, 2014, 25 (10) : 1215 - 1219
  • [9] Anti-EGFR therapies in nasopharyngeal carcinoma
    Chen, Xishan
    Liang, Renba
    Zhu, Xiaodong
    BIOMEDICINE & PHARMACOTHERAPY, 2020, 131
  • [10] Prognostic and predictive biomarkers in metastatic colorectal cancer anti-EGFR therapy
    Cristiana Lo Nigro
    Vincenzo Ricci
    Daniela Vivenza
    Cristina Granetto
    Teresa Fabozzi
    Emanuela Miraglio
    Marco C Merlano
    World Journal of Gastroenterology, 2016, (30) : 6944 - 6954
12345